Neuregulin-1 Isoform SMDF Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # AF378A

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Neutralization, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human NRG1 Isoform SMDF
Met1-Glu296
Accession # NP_039253
Met1-Glu296
Accession # NP_039253
Specificity
Detects human NRG1 Isoform SMDF in direct ELISAs and Western blots. Neutralizes 60‑80% of the biological activity of human NRG1 Isoform SMDF.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Neuregulin-1 Isoform SMDF Antibody [Allophycocyanin]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Neuregulin-1 Isoform SMDF
Alternate Names
Neuregulin1 Isoform SMDF, SMDF
Gene Symbol
NRG1
Additional Neuregulin-1 Isoform SMDF Products
Product Documents for Neuregulin-1 Isoform SMDF Antibody [Allophycocyanin]
Product Specific Notices for Neuregulin-1 Isoform SMDF Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...